Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1008-1014, March 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Syljuåsen, R. G.
Right arrow Articles by Little, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Syljuåsen, R. G.
Right arrow Articles by Little, J. B.
[Cancer Research 59, 1008-1014, March 1, 1999]
© 1999 American Association for Cancer Research


Carcinogenesis

Loss of Normal G1 Checkpoint Control Is an Early Step in Carcinogenesis, Independent of p53 Status1

Randi G. Syljuåsen, Bozena Krolewski and John B. Little2

Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115

Recent studies have described a diminished radiation-induced G1 arrest in some wild-type (wt) p53 human tumor cell lines compared to normal human fibroblasts. However, the significance of this finding was unclear, particularly because tumor cell lines may have accumulated additional genetic changes after long periods in culture. Because malignant transformation of individual cells is thought to be an early step in carcinogenesis, we have used a model system of normal and transformed mouse fibroblast 10T1/2 cell clones to examine whether loss of G1 checkpoint control may be an early event in tumor development and to study the relationships between G1 arrest, radiosensitivity, and genetic alterations. Twelve transformed clones were established from type III foci induced by irradiation of normal 10T1/2 cells and were compared with six clones derived from wt 10T1/2 cells. Three of the transformed clones expressed mutant p53; two of these had the same point mutation at codon 132 (exon 5), and one had a point mutation at codon 135. The remaining transformed and normal clones had wt p53 status. The radiosensitivity of transformed clones, as measured by a clonogenic assay, was similar to that of normal clones; the three clones with mutant p53 did not differ from the others. There was no relationship between G1 arrest and radiosensitivity. Normal 10T1/2 cell clones showed a transient G1 arrest lasting ~9 h after 6 Gy of irradiation. This G1 arrest was either absent or markedly reduced in all of the transformed clones, regardless of p53 status. These results suggest that diminished G1 checkpoint control is an early event in the process of carcinogenesis that is associated with the malignant transformation of individual cells and is independent of p53 status.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Fung, P. Liu, and B. Demple
ATF4-Dependent Oxidative Induction of the DNA Repair Enzyme Ape1 Counteracts Arsenite Cytotoxicity and Suppresses Arsenite-Mediated Mutagenesis
Mol. Cell. Biol., December 15, 2007; 27(24): 8834 - 8847.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. Balasubramaniam, P. Shannon, M. Hodaie, N. Laperriere, H. Michaels, and A. Guha
Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature
Neuro-oncol, October 1, 2007; 9(4): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
S. G. Andreev, Y. A. Eidelman, I. V. Salnikov, and I. K. Khvostunov
Mechanistic modelling of genetic and epigenetic events in radiation carcinogenesis
Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 335 - 339.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Dai, M. Rahmani, X.-Y. Pei, P. Khanna, S. I. Han, C. Mitchell, P. Dent, and S. Grant
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK
Blood, February 15, 2005; 105(4): 1706 - 1716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wharton
Repression of G0/G1 Traverse in Human Fibroblasts Exposed to Low Levels of Ionizing Radiation
J. Biol. Chem., October 15, 2004; 279(42): 43667 - 43674.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. E. Whang, C. Tran, C. Henderson, R. G. Syljuasen, N. Rozengurt, W. H. McBride, and C. L. Sawyers
c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency
PNAS, May 9, 2000; 97(10): 5486 - 5491.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. B. Little
Radiation carcinogenesis
Carcinogenesis, March 1, 2000; 21(3): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. H. Chehab, A. Malikzay, M. Appel, and T. D. Halazonetis
Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53
Genes & Dev., February 1, 2000; 14(3): 278 - 288.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.